• December 2, 2024 – Breast Cancer Lawsuit

    Published On: February 1, 2025|Categories: Zantac|By |

    A California woman has filed a lawsuit against GlaxoSmithKline, alleging that her long-term use of Zantac caused her to develop breast cancer. According to the claim, she took brand-name Zantac and generic ranitidine products between 1997 and 2018. The lawsuit states that ranitidine exposed her to harmful levels of NDMA, a chemical linked to cancer, which she believes directly contributed to her diagnosis.

    This case highlights growing concerns about the safety of Zantac and similar medications. While our firm is primarily focused on representing individuals with bladder and liver cancer claims in 2024, it’s essential for anyone affected by Zantac to understand their legal rights. If you’ve experienced health issues linked to Zantac, consult with a qualified attorney to explore your options.

  • October 28, 2024 – Update on Zantac Trial

    Published On: February 1, 2025|Categories: Zantac|By |

    The law firm Wisner Baum, along with co-counsel, has rested its case in the lawsuit Russell v. Boehringer Ingelheim Pharmaceuticals, Inc. The trial, which focuses on allegations related to Zantac and its potential cancer risks, is expected to proceed until mid to late November. This case represents one of many efforts to hold pharmaceutical companies accountable for their role in the Zantac litigation.

  • October 9, 2024 – $2.2 Billion Zantac Settlement Announced

    Published On: February 1, 2025|Categories: Zantac|By |

    GlaxoSmithKline PLC has agreed to pay up to $2.2 billion to settle more than 90% of pending U.S. state court product liability cases involving Zantac. These lawsuits claim that a discontinued version of the heartburn medication contained NDMA, a probable human carcinogen, which led to cancer in numerous users.

    This settlement marks a significant step in addressing the claims of individuals and families affected by Zantac-related health issues. If you believe Zantac may have impacted your health, now is the time to consult with experienced Zantac lawsuit attorneys to understand your legal options.

  • September 26, 2024 – First California Zantac Trial

    Published On: February 1, 2025|Categories: Zantac|By |

    The first Zantac trial in California is set to begin soon, with jury selection scheduled for next week in Alameda County Superior Court, Oakland. The trial, Russell v. Boehringer Ingelheim, is expected to start on October 7, 2024, and is anticipated to have a significant impact on the future of Zantac lawsuits nationwide.

    While many Zantac lawsuits in California have been settled before reaching trial, the defendants appear ready to take their chances with this case. The outcome of this trial will be closely monitored, as it may influence the direction and resolution of thousands of pending Zantac claims across the country.